Cao J et al (2023) TATA-box-binding protein promotes hepatocellular carcinoma metastasis through epithelial-mesenchymal transition. Hepatol Commun 7. https://doi.org/10.1097/HC9.0000000000000155

Article  Google Scholar 

Cardin GB, Bernard M, Rodier F, Christopoulos A (2021) DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma. Sci Rep 11:12753. https://doi.org/10.1038/s41598-021-92090-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen X, Xu Y (2022) Structural insights into assembly of transcription preinitiation complex. Curr Opin Struct Biol 75:102404. https://doi.org/10.1016/j.sbi.2022.102404

Article  PubMed  CAS  Google Scholar 

Chen X et al (2021) DCBLD2 mediates epithelial-mesenchymal transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma cancers (Basel). 13. https://doi.org/10.3390/cancers13061403

Chen H, Zhao X, Li Y, Zhang S, Wang Y, Wang L, Ma W (2022) High expression of TMEM33 predicts poor prognosis and promotes cell proliferation in cervical. Cancer Front Genet 13:908807. https://doi.org/10.3389/fgene.2022.908807

Article  PubMed  CAS  Google Scholar 

Fan W et al (2017) Drosophila TRF2 and TAF9 regulate lipid droplet size and phospholipid fatty acid composition. PLoS Genet 13:e1006664. https://doi.org/10.1371/journal.pgen.1006664

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng Z, Shi M, Li K, Ma Y, Jiang L, Chen H, Peng C (2020) Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma. J Transl Med 18:360. https://doi.org/10.1186/s12967-020-02527-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fu LL et al (2022) DCBLD1 overexpression is Associated with a poor prognosis in Head and Neck squamous cell. Carcinoma Front Immunol 13:939344. https://doi.org/10.3389/fimmu.2022.939344

Article  PubMed  CAS  Google Scholar 

He J et al (2020) Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer. Cell Oncol (Dordr) 43:409–420. https://doi.org/10.1007/s13402-020-00495-8

Article  PubMed  CAS  Google Scholar 

Li J, Kong WM (2022) PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer J Immunol Res 2022:4510462 https://doi.org/10.1155/2022/4510462

Li Z et al (2020) N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4. Nat Commun 11:2578. https://doi.org/10.1038/s41467-020-16306-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meng Q et al (2024) Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. J Exp Clin Cancer Res 43:36. https://doi.org/10.1186/s13046-024-02943-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pozdeyev N et al (2018) Genetic analysis of 779 Advanced differentiated and anaplastic thyroid cancers. Clin Cancer Res 24:3059–3068. https://doi.org/10.1158/1078-0432.CCR-18-0373

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schmoker AM, Ebert AM, Ballif BA (2019) The DCBLD receptor family: emerging signaling roles in development, homeostasis. Disease Biochem J 476:931–950. https://doi.org/10.1042/BCJ20190022

Article  PubMed  CAS  Google Scholar 

So KA, Lee IH, Lee KH, Hong SR, Kim YJ, Seo HH, Kim TJ (2019) Human papillomavirus genotype-specific risk in cervical carcinogenesis. J Gynecol Oncol 30:e52. https://doi.org/10.3802/jgo.2019.30.e52

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sundstrom K, Elfstrom KM (2020) Advances in cervical cancer prevention: efficacy, effectiveness. Elimination? PLoS Med 17:e1003035. https://doi.org/10.1371/journal.pmed.1003035

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA. Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  CAS  Google Scholar 

Wang Y et al (2020) SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression. Oncogene 39:4092–4102. https://doi.org/10.1038/s41388-020-1278-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang N et al (2022) Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures. Front Immunol 13:993118. https://doi.org/10.3389/fimmu.2022.993118

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang J et al (2023) Aberrant cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 14:244. https://doi.org/10.1038/s41419-023-05763-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ware AP, Satyamoorthy K, Paul B (2023) Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. Funct Integr Genomics 23:266. https://doi.org/10.1007/s10142-023-01191-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xie P, Yuan FQ, Huang MS, Zhang W, Zhou HH, Li X, Liu ZQ (2021) DCBLD2 affects the development of colorectal Cancer via EMT and angiogenesis and modulates 5-FU Drug Resistance Front. Cell Dev Biol 9:669285. https://doi.org/10.3389/fcell.2021.669285

Article  Google Scholar 

Xie P, Liu JY, Yan H, Wang ZB, Jiang SL, Li X, Liu ZQ (2022) Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker. Front Pharmacol 13:950831. https://doi.org/10.3389/fphar.2022.950831

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xin T, Ding X, Gao H, Li C, Jiang Y, Chen X (2022) Using Delphi method to develop Chinese women’s cervical cancer screening intention scale based on planned behavior theory. BMC Womens Health 22:512. https://doi.org/10.1186/s12905-022-02113-1

Article  PubMed  PubMed Central  Google Scholar 

Yu L et al (2023) T cell immunotherapy for cervical cancer: challenges and opportunities. Front Immunol 14:1105265. https://doi.org/10.3389/fimmu.2023.1105265

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zeng L, Sun X (2023) Correlation of INHBA overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer Medicina. (Kaunas) 59. https://doi.org/10.3390/medicina59030495

Zhang L et al (2019) Genomic characterization of cervical cancer based on human papillomavirus status. Gynecol Oncol 152:629–637. https://doi.org/10.1016/j.ygyno.2018.12.017

Article  PubMed  CAS  Google Scholar